Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition: Desmoid TumorInterventions: Drug: sorafenib tosylate; Other: placebo; Other: laboratory biomarker analysis; Other: quality-of-life assessmentSponsor: National Cancer Institute (NCI)Recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials